Journal
JOURNAL OF CELLULAR BIOCHEMISTRY
Volume 96, Issue 5, Pages 897-905Publisher
WILEY-LISS
DOI: 10.1002/jcb.20602
Keywords
heparanase; sulfatase; heparan sulfate proteoglycan (HSPG); tumor microenvironment; cancer
Categories
Funding
- NCI NIH HHS [CA55819, CA103054, CA68494] Funding Source: Medline
Ask authors/readers for more resources
Heparan Sulfate proteoglycans (HSPGs), via their interactions with numerous effector molecules Such as FGF-2, IL-8, and VEGF, regulate the biological activity of cells by acting as co-receptors that promote signaling. The extent and nature of their role as co-receptors is often misregulated in cancer as manifested by alterations in HSPG structure and expression level. This misregulation of HSPGs can aid in promoting the malignant phenotype. In addition to expression-related changes in HSPGs, recent discoveries indicate that HSPGs localized within the tumor microenvironment can be attacked by enzymes that alter proteoglycan structure resulting in dramatic effects on tumor growth and metastasis. This review focuses on remodeling of HSPGs by three distinct mechanisms that occur in vivo; (i) shedding of proteoglycan extracellular domains from cell Surfaces, (ii) fragmentation of heparan Sulfate chains by heparanase, and (iii) removal of sulfates from the 6-O position of heparan sulfate chains by extracellular sulfatases. Assessing or monitoring the remodeling of HSPGs has important implications for tumor diagnosis and patient prognosis while therapeutic manipulation of the remodeling process represents an exciting new possibility for treating cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available